Evaluation of microRNA expression profiles in triple-negative (ER, PR and Her2/neu) breast cancer patients with and without germ-line BRCA mutations

被引：0
|
作者：
Erturk, E. [1 ]
Cecener, G. [2 ]
Egeli, U. [2 ]
Tunca, B. [2 ]
Tezcan, G. [2 ]
Gokgoz, S. [3 ]
Tolunay, S. [4 ]
Tasdelen, I. [3 ]
机构：
[1] Uludag Univ, Vocat Sch Hlth Serv, Bursa, Turkey
[2] Uludag Univ, Fac Med, Dept Med Biol, Bursa, Turkey
[3] Uludag Univ, Fac Med, Dept Gen Surg, Bursa, Turkey
[4] Uludag Univ, Fac Med, Dept Pathol, Bursa, Turkey
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/S0959-8049(14)50355-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
398
引用
收藏
页码：S95 / S95
页数：1
相关论文
共 50 条
  • [41] Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer
    Sanomachi, Tomomi
    Okuma, Hitomi Sumiyoshi
    Kitadai, Rui
    Kawachi, Asuka
    Yazaki, Shu
    Tokura, Momoko
    Arakaki, Motoko
    Saito, Ayumi
    Kita, Shosuke
    Yamamoto, Kasumi
    Maejima, Aiko
    Kojima, Yuki
    Nishikawa, Tadaaki
    Sudo, Kazuki
    Shimoi, Tatsunori
    Noguchi, Emi
    Fujiwara, Yasuhiro
    Sugino, Hirokazu
    Shiino, Sho
    Suto, Akihiko
    Yoshida, Masayuki
    Yonemori, Kan
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [42] BRCA2 germ-line mutation screening in male breast cancer patients
    Cortés, J
    Díez, O
    Domènech, M
    Del Río, E
    Brunet, J
    Alonso, MC
    Baiget, M
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S21 - S21
  • [43] Evaluation of BRCA1 mutations in patients with triple negative breast cancer
    Ellsworth, Rachel E.
    Rummel, Seth
    Varner, Erika
    Shriver, Craig D.
    CANCER RESEARCH, 2012, 72
  • [44] Loss of the receptors ER, PR and HER2 promotes USP15-dependent stabilization of PARP1 in triple-negative breast cancer
    Xiaoxiang Sun
    Huanyin Tang
    Yu Chen
    Zhixi Chen
    Zhiyi Hu
    Zhen Cui
    Yaming Tao
    Jian Yuan
    Yun Fu
    Zhigang Zhuang
    Qizhi He
    Qian Li
    Xianghong Xu
    Xiaoping Wan
    Ying Jiang
    Zhiyong Mao
    Nature Cancer, 2023, 4 : 716 - 733
  • [45] EGFR expression and activation are common in HER2 positive and triple-negative breast tumours
    Koletsa, T.
    Kotoula, V.
    Karayannopoulou, G.
    Nenopoulou, E.
    Karkavelas, G.
    Papadimitriou, C. S.
    Kostopoulos, I.
    HISTOLOGY AND HISTOPATHOLOGY, 2010, 25 (09) : 1171 - 1179
  • [46] Loss of the receptors ER, PR and HER2 promotes USP15-dependent stabilization of PARP1 in triple-negative breast cancer
    Sun, Xiaoxiang
    Tang, Huanyin
    Chen, Yu
    Chen, Zhixi
    Hu, Zhiyi
    Cui, Zhen
    Tao, Yaming
    Yuan, Jian
    Fu, Yun
    Zhuang, Zhigang
    He, Qizhi
    Li, Qian
    Xu, Xianghong
    Wan, Xiaoping
    Jiang, Ying
    Mao, Zhiyong
    NATURE CANCER, 2023, 4 (05) : 716 - +
  • [47] Breast Carcinoma With Chondroid Differentiation: A Clinicopathologic Study of 21 Triple Negative (ER-, PR-, Her2/neu-) Cases
    Gwin, Katja
    Wheeler, Darren T.
    Bossuyt, Veerle
    Tavassoli, Fattaneh A.
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2010, 18 (01) : 27 - 35
  • [48] Serum HER2/neu levels in breast cancer patients with different level of tumor HER2/neu protein expression
    Kushlinsky, Nicolai
    Gershtein, Elena
    Shyroky, Vyacheslav
    Ermilova, Valeriya
    Tchemeris, Galina
    Letyagin, Victor
    TUMOR BIOLOGY, 2007, 28 : 95 - 95
  • [49] Branched-chain Assay for ER, PR, and HER2 RNA Levels is a Useful Adjunct in the Evaluation of ER, PR, and HER2 in Breast Cancer
    Yim, Hyeon Woo
    Song, Byung Joo
    Jung, Sang Seol
    Kim, Hyun-Joo
    Choi, Yeong-Jin
    Lee, Kyo-Young
    Lee, Ahwon
    JOURNAL OF BREAST CANCER, 2010, 13 (03) : 267 - 274
  • [50] Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer
    Rummel, Seth
    Varner, Erika
    Shriver, Craig D.
    Ellsworth, Rachel E.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (01) : 119 - 125
12345